Myeloproliferative Neoplasm — Trials

Myeloproliferative Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

4,033 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 964
Recruiting: 552
Ph III recruiting: 55
Growth YoY: +9.8%
Industry share: 22%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 37.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (699)

clinicaltrialsPublishedShowing 51–100 of 732 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06068621	Venetoclax Plus CACAG Regimen for Newly Diagnosed Acute Myeloid Leukemia	completed	Phase 2	200	Chinese PLA General HospitalOTHER	1	Jan 20, 2026	clinicaltrials
NCT00254423	Dasatinib in Treating Patients With Early Chronic Phase Chronic Myelogenous Leukemia	completed	Phase 2	150	M.D. Anderson Cancer CenterOTHER	1	Jan 15, 2026	clinicaltrials